Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progenex is a performance nutrition and life sciences company that specializes in the development of high-quality protein supplements and recovery products. Founded by Dr. Scott Connelly, the company utilizes advanced protein processing techniques, such as enzymatic hydrolysis, to create bioavailable peptide fractions designed to accelerate muscle tissue repair and growth. Their product line is primarily marketed toward elite athletes and fitness enthusiasts, focusing on the science of nutrient timing and metabolic recovery. While operating largely in the consumer health space, Progenex differentiates itself through a research-driven approach to protein synthesis and muscle metabolism.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progenex.